Elevations of CPK (Creatine Phosphokinase), generally transient and asymptomatic, were observed in 3.5% of aripiprazole treated patients as compared to 2.0% of patients who received placebo.
Kreatiinikinaasiarvon (CK) nousua, joka oli yleensä ohimenevää ja oireetonta, todettiin 3, 5 prosentilla aripipratsolia saaneista potilaista ja 2, 0 prosentilla lumeryhmän potilaista.